These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29080548)

  • 1. Efficacy of recombinant factor VIIa for severe bleeding complicated by platelet transfusion refractoriness in patients with hematologic malignancies.
    Chu T; Tang Y; Wang H; Qi J; Zhao Y; Pan T; Tang X; Qiu H; Fu C; Ruan C; Wu DP; Han Y
    Thromb Res; 2017 Dec; 160():14-18. PubMed ID: 29080548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry.
    Recht M; Rajpurkar M; Chitlur M; d'Oiron R; Zotz R; Di Minno G; Cooper DL; Poon MC
    Am J Hematol; 2017 Jul; 92(7):646-652. PubMed ID: 28370369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.
    Poon MC; d'Oiron R; Zotz RB; Bindslev N; Di Minno MN; Di Minno G;
    Haematologica; 2015 Aug; 100(8):1038-44. PubMed ID: 26001792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
    Feih JT; Juul JJ; G Rinka JR; Baumann Kreuziger LM; Pagel PS; Tawil JN
    Ann Card Anaesth; 2019; 22(4):388-393. PubMed ID: 31621674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Končar IB; Davidović LB; Savić N; Sinđelić RB; Ilić N; Dragas M; Markovic M; Kostic D
    J Vasc Surg; 2011 Apr; 53(4):1032-7. PubMed ID: 21215579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC; Di Minno G; d'Oiron R; Zotz R
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances.
    Gkiougki E; Mitsiakos G; Chatziioannidis E; Papadakis E; Nikolaidis N
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):221-6. PubMed ID: 23511491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
    Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?
    Poon MC
    Curr Hematol Rep; 2003 Mar; 2(2):139-47. PubMed ID: 12901145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
    Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
    Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery.
    Tatoulis J; Theodore S; Meswani M; Wynne R; Hon-Yap C; Powar N
    Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):459-62. PubMed ID: 19542087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation.
    Hollis AL; Lowery AV; Pajoumand M; Pham SM; Slejko JF; Tanaka KA; Mazzeffi M
    Ann Card Anaesth; 2016; 19(3):418-24. PubMed ID: 27397445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of recombinant activated factor VIIa for major bleedings in open heart surgery].
    Ingimarsson JP; Onundarson PT; Valsson F; Vidarsson B; Gudbjartsson T
    Laeknabladid; 2008 Sep; 94(9):607-12. PubMed ID: 18784387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits.
    Tranholm M; Rojkjaer R; Pyke C; Kristensen AT; Klitgaard B; Lollike K; Blajchman MA
    Thromb Res; 2003 Feb; 109(4):217-23. PubMed ID: 12757777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant factor VIIa as last-resort treatment of desperate haemorrhage.
    Palmason R; Vidarsson B; Sigvaldason K; Ingimarsson JP; Gudbjartsson T; Sigurdsson GH; Onundarson PT
    Acta Anaesthesiol Scand; 2012 May; 56(5):636-44. PubMed ID: 22489992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.
    Phillips LE; McLintock C; Pollock W; Gatt S; Popham P; Jankelowitz G; Ogle R; Cameron PA;
    Anesth Analg; 2009 Dec; 109(6):1908-15. PubMed ID: 19923520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia.
    Andiç N; Oğuz N; Gündüz E; Kiraz Bulduk T; Üsküdar Teke H
    Blood Coagul Fibrinolysis; 2021 Jul; 32(5):349-351. PubMed ID: 33878047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.